Research and Markets (http://www.researchandmarkets.com/research/3d7db5/cancer_diagnostic) has announced the addition of the "Cancer Diagnostic Technologies: Assessment of Current and Emerging Technologies, and Their Potential Market Applications" report to their offering.
This report provides detailed assessments of such technologies as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.
Key Topics Covered:
Current and Emerging Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays a. Technological Principle b. Radioimmunoassay (RIA) c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Immunofiltration
- Particle-Membrane Capture Immunoassay
- Enzyme Amplification
- Fluorescent Immunoassays e. Luminescence
- Chemiluminescence
- Bioluminescence
3. Molecular Diagnostics a. Technology Overview b. Amplification Methods
- PCR
- DAP-PCR
- Immuno-PCR
- QC-PCR
- CAR
- DNA
- HPA
- LCR
- NASBA
- QBR
- SDA
- 3 SR, and others
4. Biochips/Microarrays
5. Chromosome Analysis a. Chronic Myelogenous Leukemia (CML) b. Acute Myeloid Leukemia (AML) c. Acute Lymphoblastic Leukemia (ALL) d. Malignant Lymphomas
Lymphoid Malignancies e. Chronic Lymphocytic Leukemia (CLL) f. Solid Cancers g. Chromosomal Translocation and Oncogenes
6. Microcomputers and Automation
7. Artificial Intelligence
8. Flow Cytometry
9. Biosensors E. Competing/Complementing Technologies:
- CT
- MRI
- NMR
- PET
- Photonics Spectroscopy
http://www.researchandmarkets.com
Subscribe